Traditional Chinese medicine oral medicine for treating granulation neoplastic mastitis in lump stage based on nerve-endocrine-immune network

Through the traditional Chinese medicine formula based on the neuro-endocrine-immune network, the body functions under the liver meridian heat accumulation syndrome are regulated, and the problems of poor effect and high recurrence rate of granulomatous mastitis treatment are solved, achieving efficient improvement of immune function and The downregulation of inflammatory factors provides a safer treatment plan.

CN119015377APending Publication Date: 2024-11-26TAICANG HOSPITAL OF TRADITIONAL CHINESE MEDICINE
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
CN202411169841.5
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-25
Publication Date
2024-11-26

AI Technical Summary

Technical Problem

The prior art lacks effective traditional Chinese medicine oral drugs for the treatment of granulomatous mastitis, especially in the liver meridian heat-containing state during the lump period, making it difficult to regulate the neuro-endocrine-immune network, resulting in poor treatment effect and high recurrence rate.

Method used

A Chinese medicine oral drug formula based on the neuro-endocrine-immune network is adopted, including raw rehmannia, white peony, angelica, Chuanxiong, Bupleurum, Xiangfu, Qingshe, rose, raw malt, whole Trichosanthes, soap thorns, and sarcoidae , small pollen, dandelion and forsythia, regulate the NEI network by regulating the liver and unblocking the meridians, relieving liver qi, relieving depression and dispersing nodules, improving immune function and downregulating inflammatory factors.

Benefits of technology

It significantly improves the overall effective efficiency of the treatment of granulomatous mastitis in the lump stage, reduces the level of traditional Chinese medicine syndrome points and inflammatory factors, reduces adverse reactions and recurrence rates, and has higher efficacy and safety than hormone drugs.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure BDA0005008955380000091
    Figure BDA0005008955380000091
  • Figure BDA0005008955380000101
    Figure BDA0005008955380000101
  • Figure BDA0005008955380000102
    Figure BDA0005008955380000102
Patent Text Reader

Abstract

The invention relates to a nerve-endocrine-immune network-based traditional Chinese medicine oral medicine for treating granulation neoplastic mastitis in a lump stage, which is prepared from the following raw materials in parts by weight: 15 to 25g of radix rehmanniae, 25 to 35g of radix paeoniae alba, 15 to 25g of radix angelicae sinensis, 15 to 25g of rhizoma chuanxiong, 10 to 20g of radix bupleuri, 10 to 20g of rhizoma cyperi, 10 to 20g of pericarpium citri reticulatae viride, 10 to 15g of flos rosae rugosae, 15 to 25g of raw malt and 15 to 25g of fructus trichosanthis. The traditional Chinese medicine is prepared from 15-25 g of spina gleditsiae, 15-25 g of bombyx batryticatus, 10-20 g of radix trichosanthis The traditional Chinese medicine composition has the advantages that on one hand, compatibility is performed according to the traditional Chinese medicine dialectical theory, liver regulating and collateral dredging are achieved, pathogenesis is matched, local and clinical curative effects are considered constantly; and on the other hand, from a modern physiological action mechanism and a nerve-endocrine-immune network, the overall function behavior of the body in the state of the liver channel intrinsic heat syndrome of the mastitis granulosa and the relationship among different levels of the body are explored, and the action mechanism for treating the mastitis granulosa with the liver channel intrinsic heat syndrome of the mastitis granulosa is excavated. The traditional Chinese medicine composition supplements the treatment of the granulomatous mastitis in a dialectical manner, and is convenient for better treatment of the granulomatous mastitis.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the technical field of medicine, in particular to an oral Chinese medicine for treating the mass stage of granulomatous mastitis based on a nerve-endocrine-immune network. Background Art

[0002] Granulomatous lobular mastitis (GLM) is a chronic, non-infectious breast inflammation disease with non-caseous necrotic breast tissue granulomas distributed in the breast lobules. It is also called granulomatous lobular inflammation and breast granuloma. Chinese medicine calls it "acne-like mastitis". It is characterized by a long course of disease and a high recurrence rate. Its pathogenesis is still unclear and its treatment is quite difficult. In recent years, the incidence of granulomatous mastitis has shown a growing trend. From the clinical manifestations, granulomatous mastitis (GLM) is mainly characterized by nodules or lumps in the early stage, which may develop into abscesses in the middle stage, and rupture and discharge pus in the late stage, gradually forming fistulas or sinuses, which are difficult to heal. In addition, GLM is more common in young and middle-aged women, who have a high aesthetic pursuit and damaged breast appearance, causing great harm to them both physically and psychologically. However, some scholars [6] pointed out that if GLM is actively treated in the early stage of onset, it may promote the complete disappearance of the lesions, which has a positive significance in blocking the progression and aggravation of the disease. Because the pathogenesis of granulomatous mastitis is still unclear, there is no standardized and effective treatment method. Oral hormone therapy is usually used, which can effectively control the scope of the lesion, but the long-term use of hormone drugs has a high incidence of adverse reactions and is prone to recurrence.

[0003] Traditional Chinese medicine has its unique advantages in treating GLM. According to the clinical characteristics of granulomatous mastitis, traditional Chinese medicine classifies it as "breast abscess". When studying the prescriptions of the Yanjing School of Surgery for the treatment of granulomatous mastitis through data mining, it was found that the liver meridian and spleen meridian accounted for the highest proportion of meridians. Because the foot jueyin meridian and foot yangming meridian pass through the nipple and breast, breast diseases in women are often treated from the perspective of liver and stomach. Moreover, this disease often occurs in the areola area and is closely related to the liver meridian. Ye Tianshi's "Clinical Guide Medical Cases" says: "Women are born with liver." "The Authentic Surgery. Breast Abscess and Breast Rock Theory" says: "Husbands with breast diseases... depression hurts the liver, liver qi stagnation and swelling... depression hurts the liver..., causing the meridians to be astringent and agglomerate into nuclei." The liver is responsible for dredging and dispersing, and dominates the rise and fall of qi, blood, and body fluids in the body. Therefore, if the liver's qi is abnormal, the distribution of qi, blood, and body fluids will be abnormal. In addition, the liver is the seat of blood, and the liver is yin in nature but uses yang. Its function of dispersing and discharging is also based on the normal function of storing blood. Nourishing blood and softening the liver can regulate liver qi. On the contrary, if qi and blood are not smooth, liver deficiency and stagnation will occur, and milk vessels will be blocked. Over time, the liver will accumulate heat, and the heat will steam the flesh and rot, forming carbuncle.

[0004] Chinese patent document CN201110092315.X, application date 2011-04-13, patent name: a Chinese medicine for treating breast diseases; discloses a Chinese medicine for treating breast diseases, which is composed of a mixture of angelica, red peony root, peach kernel, safflower, salvia miltiorrhiza, zedoaria, corydalis, chuanxiong, earthworm, jiazhu, lou lu, thunbergia thunbergii, licorice, radix scutellariae, radix scutellariae, radix angelicae, radix trichosanthis, oyster, citrus aurantii, cyperus rotundus, citrus seed, bupleurum, dandelion, trichosanthes, forsythia, astragalus, codonopsis pilosula, liquorice, frankincense, myrrh, tuckahoe and oldenlandia diffusa. The Chinese medicine has the effects of invigorating qi and blood, promoting blood circulation and softening hard masses, unblocking meridians and detoxifying, soothing the liver and regulating qi, softening hard masses and dispersing lumps, strengthening the spleen and resolving phlegm, strengthening the body and eliminating evil, and can treat breast hyperplasia, acute and chronic mastitis, breast fibroadenoma, intraductal papilloma, breast ailment, mastitis, mastitis and breast abscess.

[0005] The above scheme is to treat breast-related diseases based on the theory of traditional Chinese medicine. It is not targeted and has general efficacy. There is no specific public technical scheme specifically for the treatment of granulomatous mastitis.

[0006] In summary, there is an urgent need for a technical solution to explore the overall functional behavior of the body and the relationship between its different levels under the state of liver meridian heat accumulation syndrome in granulomatous mastitis in the mass stage from the perspective of neuro-endocrine-immune network, so as to explore the oral Chinese medicine for the treatment of granulomatous mastitis. However, no reports on this technical solution have been seen so far. Summary of the invention

[0007] The purpose of the present invention is to provide an exploration of the overall functional behavior of the body and the relationship between its various levels under the liver meridian heat accumulation syndrome state in granulomatous mastitis at the mass stage from the perspective of the neuro-endocrine-immune network, so as to explore oral Chinese medicine for the treatment of granulomatous mastitis.

[0008] A Chinese herbal oral medicine for treating the mass stage of granulomatous mastitis based on a neuro-endocrine-immune network, wherein the raw material composition and weight fraction of the effective ingredients of the Chinese herbal oral medicine are:

[0009] 15-25g of raw rehmannia, 25-35g of white peony root, 15-25g of angelica, 15-25g of chuanxiong, 10-20g of bupleurum, 10-20g of cyperus, 10-20g of green tangerine peel, 10-15g of rose, 15-25g of raw malt, 15-25g of whole trichosanthes, 15-25g of sapodilla thorn, 15-25g of bombyx batryticatus, 10-20g of trichosanthes, 10-20g of dandelion, and 10-20g of forsythia.

[0010] As a preferred technical solution, the raw material composition and weight fraction of the effective ingredients of the oral Chinese medicine are: 20g of raw rehmannia, 30g of white peony root, 20g of angelica, 20g of ligusticum chuanxiong, 15g of bupleurum, 15g of cyperus rotundus, 15g of green peel, 10g of rose, 15g of raw malt, 20g of whole trichosanthes, 20g of sapodilla thorn, 20g of bombyx batryticatus, 15g of trichosanthes root, 15g of dandelion, and 15g of forsythia.

[0011] As a preferred technical solution, the raw material composition and weight fraction of the effective ingredients of the oral Chinese medicine are: 15g of raw rehmannia, 25g of white peony root, 15g of angelica, 15g of chuanxiong, 10g of bupleurum, 10g of cyperus, 10g of green peel, 10g of rose, 15g of raw malt, 15g of whole trichosanthes, 15g of sapodilla spines, 15g of bombyx batryticatus, 10g of trichosanthes, 10g of dandelion, and 10g of forsythia.

[0012] As a preferred technical solution, the raw material composition and weight fraction of the effective ingredients of the oral Chinese medicine are: 25g of raw rehmannia, 30g of white peony root, 25g of angelica, 25g of chuanxiong, 20g of bupleurum, 20g of cyperus, 20g of green peel, 15g of rose, 25g of raw malt, 25g of whole trichosanthes, 25g of sapodilla spines, 25g of bombyx batryticatus, 20g of trichosanthes, 20g of dandelion, and 20g of forsythia.

[0013] As a preferred technical solution, the bupleurum is vinegar bupleurum.

[0014] The second object of the present invention is to provide a method for preparing a traditional Chinese medicine oral medicine for treating the mass stage of granulomatous mastitis based on the nerve-endocrine-immune network.

[0015] To achieve the above object, the technical solution adopted by the present invention is:

[0016] A method for preparing an oral Chinese medicine for treating the mass stage of granulomatous mastitis based on the neuro-endocrine-immune network described in the above embodiment, characterized in that it comprises the following steps:

[0017] S1: Weigh raw rehmannia root, white peony root, Chinese angelica root, ligusticum chuanxiong, bupleurum root, cyperus rotundus, green peel, rose flower, raw malt, whole trichosanthes root, licorice thorn, bombyx batryticatus, radix trichosanthis, dandelion, forsythia suspensa by weight, wash and mix, microwave-dry and set aside;

[0018] S2: the raw material prepared in step S1 is chopped, boiled in water for 1-2 hours, filtered, and the residue is boiled in water for another 1-2 hours, the two filtrates are combined, concentrated, and cooled naturally;

[0019] S3: Add pharmaceutical excipients, package and sterilize to obtain oral solution.

[0020] As a preferred technical solution, the pharmaceutical excipient in step S3 is sucrose or monosaccharide syrup.

[0021] The present invention has the advantages that:

[0022] 1. The oral Chinese medicine of the present invention is compatible according to the theory of syndrome differentiation of traditional Chinese medicine, regulates the liver and dredges the meridians, conforms to the pathogenesis, and always takes local into consideration, and has a good clinical effect; on the other hand, from the perspective of modern physiological mechanism of action and the neuro-endocrine-immune network, the overall functional behavior of the body under the state of liver meridian accumulation heat syndrome in granulomatous mastitis in the mass stage and the relationship between its various different levels are explored, the mechanism of action of treating granulomatous mastitis in the liver meridian accumulation heat syndrome in the mass stage is excavated, the syndrome differentiation treatment of granulomatous mastitis is supplemented, and it is convenient for better treatment of granulomatous mastitis.

[0023] 2. The oral Chinese medicine of the present invention intervenes in the treatment of granulomatous mastitis with liver meridian heat accumulation syndrome in the mass stage from the perspective of modern physiological mechanism, that is, from the perspective of the neuro-endocrine-immune network, the overall functional behavior of the body under the state of liver meridian heat accumulation syndrome in the mass stage granulomatous mastitis and the relationship between its various levels are explored, thereby exploring the utility principle of establishing a steady-state balance in the neuro-endocrine-immune (NEI) network, thereby achieving the regulation of the NEI network, improving immune function, and downregulating inflammatory factors. It has a significant effect on the treatment of granulomatous mastitis with liver meridian heat accumulation syndrome in the mass stage.

[0024] 3. The Chinese medicine oral medicine of the present invention has its unique advantages in treating GLM. According to the clinical characteristics of the onset of granulomatous mastitis, Chinese medicine classifies it as "breast abscess" category. When the prescription of Yanjing surgical school for treating granulomatous mastitis was studied by data mining, it was found that the liver meridian and spleen meridian had the highest proportion in the meridians. Because the foot jueyin meridian and foot yangming meridian pass through the nipple and breast, women's breast diseases are mostly treated from the liver and stomach. And this disease is more common in the areola, and is closely related to the liver meridian. Ye Tianshi's "Clinical Guide Medical Case" says: "Women are born with liver". "Surgery Authentic. Breast Abscess Breast Rock Theory" says: "Husband breast disease... depression hurts the liver, liver qi stagnation and swelling... depression hurts the liver again..., causing meridians to be astringent and agglomerate into nuclei". The liver governs the dredging and discharging, and dominates the rise and fall of the qi, blood and body fluids of the whole body. Therefore, if the qi mechanism of the liver is abnormal, the distribution of qi, blood and body fluids is abnormal. In addition, the liver is the palace of blood. The liver is yin in nature but yang in function. The function of its drainage is also based on the normal function of storing blood. Nourishing blood and softening the liver can regulate liver qi. On the contrary, if qi and blood are not smooth, liver deficiency and stagnation will occur, and the milk collaterals will be blocked. After a long time, the heat will steam the meat and rot, and then carbuncle will form. This program insists on regulating the liver as the first priority, softening the liver and dredging the liver to treat the root cause. The so-called "the meridians are affected by evil and enter the internal organs, which is caused by the internal factors" and "what is inside will be outside". And follow the principle of "the collaterals are used for communication", and match the drugs that directly have the functions of regulating qi and unblocking collaterals, clearing heat and dispersing knots, so as to make the milk collaterals unblocked and the qi and blood yin and yang harmonized. And match according to the principle of monarch, minister, assistant and envoy: monarch medicine: raw rehmannia, white peony root; minister medicine: angelica, Chuanxiong; adjuvant medicine: bupleurum, cyperus, green peel, rose, raw malt; envoy medicine: whole trichosanthes, sapodilla thorn, bombyx batryticatus, radix trichosanthis, dandelion, forsythia suspensa. The combination of yin and soft herbs (blood-in-blood medicine) of Radix Rehmanniae and Radix Paeoniae Alba and spicy and fragrant Radix Angelicae Sinensis and Rhizoma Chuanxiong (blood-in-qi medicine) combines movement and stillness, nourishes without stagnation, nourishes without being greasy. All four herbs enter the liver meridian, nourish blood and soften the liver, and can also cure blood deficiency and fire movement, which also means "treat the blood first to treat the collaterals, and the blood and collaterals will be unblocked by themselves"; and bupleurum, cyperus rotundus, green peel, rose flower, and raw malt are used to soothe the liver and relieve depression, regulate qi and dredge the collaterals. The first three are focused on soothing the liver, and the last two are focused on relieving depression; whole Trichosanthes, Gleditsia sinensis, Bombyx batryticatus, Radix Trichosanthis are used to dredge the collaterals and disperse the knots, and dandelion and forsythia are used to penetrate the surface and clear the depression and heat, and prevent it from developing into carbuncle. Regulating the liver and unblocking the collaterals is in line with the pathogenesis, and it always takes into account the local situation, and the clinical effect is quite good.

[0025] 4. In the Chinese medicine formula of the present invention, Bupleurum is the dry root of the Umbelliferae plant Bupleurum or Angustifolia, which is pungent and bitter in taste, slightly cold in nature, and enters the liver, gallbladder, and lung meridians, and can reconcile the exterior and interior, relieve liver and relieve depression, raise yang and lift depression, and reduce fever and cut off cruelty. However, the single Bupleurum effect is not significant and cannot meet the current needs. The present invention adopts vinegar Bupleurum. On the one hand, Bupleurum enters the liver and gallbladder meridians. After being soaked in rice vinegar, the vinegar Bupleurum mainly enters the liver meridian, which can alleviate its own ascending and dispersing nature, and the effects of soothing liver and relieving depression and stopping pain with blood are significantly enhanced; on the other hand, the Bupleurum saponins in the vinegar Bupleurum after vinegar roasting are significantly increased, and there are better anti-inflammatory and immunity-enhancing functions. Therefore, the present invention selects vinegar Bupleurum to be crushed and used as medicine, and the effects of soothing liver and relieving depression and stopping pain with blood and improving the immunity of the patient's body are significantly enhanced.

[0026] 5. In the Chinese medicine formula of the present invention, according to the TCM syndrome differentiation of granulomatous mastitis, the compatibility prescription is equipped with Radix Rehmanniae and Radix Paeoniae Alba, which are soft and feminine products and blood-blood medicines. They are matched with the spicy Radix Angelicae Sinensis and Rhizoma Chuanxiong (blood-qi medicines), and the combination of movement and stillness can replenish without stagnation, nourish without being greasy, and the four substances all enter the liver meridian, nourish blood and soften the liver, and can also treat blood deficiency and fire, and also have the meaning of "treating collaterals first, and blood and collaterals are naturally connected". From the perspective of modern physiology, IgM and IgG are mainly influencing factors of immunity. On the surface, Radix Paeoniae Alba and Radix Rehmanniae have a significant effect on the regulation in the immune network link when establishing the balance of the neuro-endocrine-immune network.

[0027] 6. In the Chinese medicine formula of the present invention, according to the TCM differentiation of granulomatous mastitis, the compatibility has two medicinal flavors of rose and raw malt. Rose and raw malt focus on relieving depression, regulating qi and unblocking collaterals. Rose has the effects of promoting qi and relieving depression, promoting blood circulation and regulating menstruation. Raw malt strengthens the spleen and stomach and promotes lactation, and is used for spleen deficiency, less food intake, and milk sweat accumulation. From the perspective of modern physiology, when establishing the balance of the nerve-endocrine-immune network; it mainly has a significant effect on promoting balance in the endocrine link.

[0028] 7. The Chinese medicine formula of the present invention has the effects of dredging meridians and dispersing nodules according to the TCM differentiation of granulomatous mastitis, regulating the liver and dredging meridians, conforming to the pathogenesis, and taking local conditions into consideration from time to time, and has a good clinical effect. DETAILED DESCRIPTION

[0029] Example 1 Chinese medicine oral medication

[0030] An oral Chinese medicine for treating granulomatous mastitis in the mass stage based on a neuro-endocrine-immune network; comprising: 15-25g of Radix Rehmanniae, 25-35g of Radix Paeoniae Alba, 15-25g of Radix Angelicae Sinensis, 15-25g of Rhizoma Chuanxiong, 10-20g of Radix Bupleuri, 10-20g of Rhizoma Cyperi, 10-20g of Pericarpium Citri Reticulatae, 10-15g of Flos Rosae Rugosae, 15-25g of Rhizoma Trichosanthis, 15-25g of Spinosa Psoraleae, 15-25g of Bombyx Batryticatus, 10-20g of Radix Trichosanthis, 10-20g of Herba Taraxaci, and 10-20g of Fructus Forsythiae.

[0031] Preparation method:

[0032] S1: Weigh raw rehmannia root, white peony root, Chinese angelica root, ligusticum chuanxiong, bupleurum root, cyperus rotundus, green peel, rose flower, raw malt, whole trichosanthes root, licorice thorn, bombyx batryticatus, radix trichosanthis, dandelion, forsythia suspensa by weight, wash and mix, microwave-dry and set aside;

[0033] S2: the raw material prepared in step S1 is chopped, boiled in water for 1-2 hours, filtered, and the residue is boiled in water for another 1-2 hours, the two filtrates are combined, concentrated, and cooled naturally;

[0034] S3: Add pharmaceutical excipients, package and sterilize to obtain oral solution.

[0035] Example 2 Chinese medicine oral medication

[0036] 20g of raw rehmannia, 30g of white peony root, 20g of angelica, 20g of chuanxiong, 15g of bupleurum, 15g of cyperus rotundus, 15g of green peel, 10g of rose, 15g of raw malt, 20g of whole trichosanthes, 20g of sapodilla thorn, 20g of bombyx batryticatus, 15g of trichosanthes, 15g of dandelion, and 15g of forsythia.

[0037] The preparation method is the same as Example 1.

[0038] Example 3 Chinese medicine oral medication

[0039] 15g of Radix Rehmanniae, 25g of Radix Paeoniae Alba, 15g of Radix Angelicae Sinensis, 15g of Rhizoma Chuanxiong, 10g of Radix Bupleuri, 10g of Rhizoma Cyperi, 10g of Rhizoma Cibotii, 10g of Rose, 15g of Malt, 15g of Rhizoma Trichosanthis, 15g of Rhizoma Gleditsiae, 15g of Bombyx Batryticatus, 10g of Radix Trichosanthis, 10g of Herba Taraxaci, 10g of Fructus Forsythiae;

[0040] The preparation method is the same as Example 1.

[0041] Example 4 Chinese medicine oral medication

[0042] 25g of Radix Rehmanniae, 30g of White Peony Root, 25g of Angelica Sinensis, 25g of Rhizoma Chuanxiong, 20g of Radix Bupleuri, 20g of Rhizoma Cyperi, 20g of Rhizoma Cibotii, 15g of Rose, 25g of Malt, 25g of Rhizoma Trichosanthis, 25g of Gleditsiae Spinosa, 25g of Bombyx Batryticatus, 20g of Radix Trichosanthis, 20g of Herba Taraxaci, 20g of Fructus Forsythiae;

[0043] The preparation method is the same as Example 1.

[0044] Example 5 Chinese medicine oral medication

[0045] 15g of raw rehmannia, 15g of angelica, 15g of chuanxiong, 10g of bupleurum, 10g of cyperus, 10g of green peel, 10g of rose, 15g of raw malt, 15g of whole trichosanthes, 15g of sapodilla thorn, 15g of bombyx batryticatus, 10g of trichosanthes, 10g of dandelion, and 10g of forsythia.

[0046] The preparation method is the same as Example 1.

[0047] Example 6 Chinese medicine oral medication

[0048] 15g of Radix Rehmanniae, 25g of Radix Paeoniae Alba, 15g of Radix Angelicae Sinensis, 15g of Rhizoma Chuanxiong, 10g of Radix Bupleuri, 10g of Rhizoma Cyperi, 10g of Rhizoma Cibotii, 10g of Rose, 15g of Malt, 15g of Rhizoma Trichosanthis, 15g of Rhizoma Gleditsiae, 15g of Bombyx Batryticatus, 10g of Radix Trichosanthis, 10g of Herba Taraxaci, 10g of Fructus Forsythiae;

[0049] The preparation method is the same as Example 1.

[0050] Example 7 Chinese medicine oral medication

[0051] 15g of Radix Rehmanniae, 25g of Radix Paeoniae Alba, 15g of Radix Angelicae Sinensis, 15g of Rhizoma Chuanxiong, 10g of Radix Bupleuri, 10g of Rhizoma Cyperi, 10g of Rhizoma Cibotii, 10g of Rose, 15g of Malt, 15g of Rhizoma Trichosanthis, 15g of Rhizoma Gleditsiae, 15g of Bombyx Batryticatus, 10g of Radix Trichosanthis, 10g of Herba Taraxaci, 10g of Fructus Forsythiae;

[0052] The preparation method is the same as Example 1.

[0053] Experimental Example 1

[0054] Materials and Methods

[0055] 1Diagnostic criteria

[0056] 1.1 Western medicine diagnostic criteria

[0057] Pathological tissue biopsy is the "gold standard" for diagnosing GLM. Referring to the pathological changes of granulomatous lobular mastitis in "Breast Pathology" (Edited by Xu Liangzhong, Shanghai Medical University Press, 1999) and "Diagnosis and Differential Diagnosis of Breast Pathology" (Edited by Ding Huaye, People's Medical Publishing House, 2014), the specific microscopic manifestations are: granulomatous inflammation centered on the terminal duct lobular unit of the breast, which may be surrounded by proliferative fibrous tissue. The lesions are multifocal and can fuse. The lobular structure is atrophic or disappears. Various inflammatory cell infiltrations can be seen in the lobules, mainly neutrophils, which may be accompanied by lipid vacuoles and microabscess formation.

[0058] 1.2 Standards for TCM Syndrome Differentiation

[0059] It is consistent with the syndrome of liver meridian stagnation and heat in Traditional Chinese Medicine Surgery (Edited by Chen Hongfeng, People's Medical Publishing House, 2014): (1) Main symptoms: purulent and bloody discharge from the nipple, inverted nipple, and a lump with unclear boundaries that can be felt in the breast; (2) Secondary symptoms: fever, headache, weakness in the limbs, dry stool, red and yellow urine, and a stringy and slippery pulse. On the basis of meeting the main symptoms, two of the secondary symptoms must be met, and then combined with tongue and pulse differentiation to confirm the diagnosis.

[0060] 2 Inclusion criteria

[0061] (1) Pathological diagnosis of granulomatous lobular mastitis; (2) diagnosis of comedonal mastitis with liver meridian heat accumulation syndrome; (3) patients with mass type, and ultrasound examination showed no abscess liquefaction in the lesion; (4) no oral treatment with Chinese medicine after onset; (5) no use of hormone preparations in the past six months; (6) good compliance, willing to participate in this study and accept follow-up after discharge.

[0062] 3 Exclusion criteria

[0063] (1) Patients with serious primary diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system; (2) Patients with combined endocrine system, nervous system and immune system diseases; (3) Patients with infections in other parts of the body; (4) Patients with mental or legal disabilities who cannot cooperate with treatment; (5) Patients with missing clinical case data; (6) Patients who are allergic to the study drugs.

[0064] 4 Shedding Standard

[0065] (1) Patients with poor compliance during the trial study, which affects the evaluation of treatment effectiveness and safety; (2) Patients who withdraw from the trial before the end of the treatment due to various other reasons.

[0066] 5 General Information

[0067] A total of 75 GLM patients were finally included in this study, all from the Thyroid and Breast Surgery Ward of Taicang Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Chinese Medicine from October 2020 to October 2023. The study adopted a prospective, randomized, and controlled method, and the patients were divided into a control group and a treatment group. There were 39 cases in the control group, 1 case was excluded, and 1 case dropped out, a total of 37 cases completed the study; there were 41 cases in the treatment group, 2 cases were excluded, and 1 case dropped out, a total of 38 cases completed the study. Control group: aged 23-45 years old, with an average age of (33.6±3.9) years old, 36 cases were married and had a history of breastfeeding, 0 cases were married but not childless, 1 case was unmarried and childless, 31 cases with varying degrees of nipple inversion deformity, 18 cases (56.25%) had a history of milk accumulation during lactation, the course of disease was 1-31d, the average course of disease was (11.2±3.7)d, and the size of the mass ranged from 5 to 139cm when the patients were enrolled. 2 The experimental group: aged 21-44 years, with an average age of (34.5±3.4) years, 36 married women with a history of breastfeeding, 1 married woman without children, 1 unmarried woman without children, 32 with different degrees of nipple inversion, 21 with a history of milk accumulation during lactation (60.71%), 2-28 days of disease course, with an average course of (12.1±4.3) days, and the size of the tumor ranged from 7 to 111 cm when the patients were enrolled. 2There was no significant difference in the general data between the two groups (P>0.05). This study was approved by the Medical Ethics Committee of Taicang Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Chinese Medicine (Taicang Ethics Review (2019) No. (014)).

[0068] 6 Treatments

[0069] During the treatment period, both groups of patients were given external application of Jinhuang Powder, which consisted of powdered Radix Trichosanthis, Radix Rhei, Cortex Phellodendri, Curcuma Longa, Angelica Dahuricae, Rhizoma Arisaematis, Pericarpium Citri Reticulatae, Rhizoma Atractylodis Macrocephalae, Cortex Magnoliae, and Radix Glycyrrhizae, mixed with appropriate amount of water to form a paste, and then spread thinly on gauze and applied to the affected breast, twice a day, each time for 4 hours. The course of treatment was 4 weeks, and treatment was stopped if the patient recovered during the period.

[0070] 6.1 Control group

[0071] On the basis of external treatment with traditional Chinese medicine, oral administration of prednisone acetate tablets [Tianjin Xinyi Jinjin Pharmaceutical Co., Ltd., national medicine standard H31020675], 30 mg / d -1 , reduce by 5 mg / d per week from the 3rd week -1 , reduce to 5 mg / d -1 , maintain treatment for 1 week. Add or subtract dosage according to the condition.

[0072] 6.2 Treatment Groups

[0073] On the basis of external treatment with traditional Chinese medicine, oral prescription for soothing liver and unblocking meridians was given. Prescription: 20g of raw earth, 30g of white peony root, 20g of angelica, 20g of chuanxiong, 15g of bupleurum, 15g of cyperus, 15g of green peel, 10g of rose, 15g of raw malt, 20g of whole trichosanthes, 20g of sapodilla thorn, 20g of bombyx batryticatus, 15g of radix trichosanthis, 15g of dandelion, 15g of forsythia. One dose per day, uniformly decocted by Tianling Pharmaceutical, taken warm in the morning and evening. The course of treatment is 4 weeks, and the treatment is stopped if the patient recovers during the period.

[0074] 7 Observation indicators

[0075] The clinical symptoms, physical signs, inflammatory factors, neurotransmitters, prolactin and immune indexes before and after treatment were compared between the two groups. Adverse reactions (itching, rash, loss of appetite, nausea, vomiting, dizziness, palpitations and abnormal liver and kidney function) were observed during medication. After treatment, the patients who were cured, markedly effective and effective were followed up for 6 months to compare the recurrence rate between the two groups. (1) Clinical symptoms and physical signs: The clinical symptoms and physical signs scores were evaluated with reference to the "Guidelines for Clinical Research of New Chinese Medicines" (Edited by Zheng Xiaoyu, China Medical Science and Technology Press, 2002). ① Breast pain score: no local pain, scored as 0 points; mild pain, scored as 2 points; obvious local pain but tolerable, scored as 4 points; severe pain that affects sleep, scored as 6 points. ②Breast mass score: 0 points if the local mass diameter is reduced by <2cm, the mass is hard, or there is a new mass; 4 points if the mass diameter is reduced by 2-3cm and the mass becomes tough; 6 points if the mass diameter is reduced by >3cm and the mass becomes soft. ③Local skin condition score: 0 points if the local skin color is normal and there is no slight heat sensation; 4 points if the local skin color is red and there is a weak heat sensation; 6 points if the local skin is ulcerated. The efficacy was evaluated with reference to "Breast Disease" (Edited by Harris (USA), translated by Wang Yongsheng, Shandong Science and Technology Press, 2018) and "Guidelines for Clinical Research of New Chinese Medicines". Clinical cure: breast lump completely disappears, no redness, swelling, heat or pain, no chronic inflammation changes in breast ultrasound examination, TCM symptom score reduced by ≥90%; marked effect: breast lump reduced by >50%, but still hard locally, with symptoms disappeared, TCM symptom score reduced by 60%-89%; effective: breast lump reduced, but less than 50%, with symptoms improved, TCM symptom score reduced by 40%-59%; ineffective: breast lump did not change or increased, even abscess, ulcer sinus tract appeared, needing surgical treatment, TCM symptom score reduced by <40%. Total effective rate = (clinical cure + marked effect + effective) cases / total cases × 100%. (2) Serum neurotransmitters: HPLC / MS method was used to determine the levels of 5-hydroxytryptamine (5-HT) and norepinephrine (NE) before and after treatment. (3) Prolactin (PRL): Enzyme-linked immunosorbent assay was used to detect serum PRL value, and the changes in serum PRL levels before and after treatment were compared between the two groups. (4) Serum immune indexes: The levels of IgG and IgM in the two groups before and after treatment were detected by immunoturbidimetry. (5) Serum inflammatory factors: The levels of interleukin-6 (IL-6) and tumor necrosis factor α (TNF-α) were detected by enzyme-linked immunosorbent assay.

[0076] 8 Statistical methods

[0077] The research data were statistically processed using SPSS17.0 software. The measurement data were described as xˉ±s. For normally distributed data, the t-test was used for inter-group comparison, and the rank-sum test was used for comparison of data that did not conform to the normal distribution. The chi-square test was used for counting data, and P<0.05 was considered statistically significant.

[0078] result

[0079] 1 Comparison of clinical efficacy between the two groups

[0080] In this study, 9 patients in the treatment group were cured, 15 were markedly effective, 11 were effective, and the total effective rate was 92.10%. In the control group, 4 patients were cured, 8 were markedly effective, 19 were effective, and the total effective rate was 83.78%. Compared with the control group, the total effective rate in the treatment group was higher, and the difference was statistically significant (P<0.01). See Table 1.

[0081] Table 1 Comparison of clinical efficacy of granulomatous mastitis between two groups

[0082]

[0083] 2 Comparison of TCM syndrome scores between the two groups before and after treatment

[0084] After treatment, the TCM syndrome score of the treatment group decreased from 14.58±2.78 to 5.71±1.12, which was statistically significant (P<0.01). Compared with the other groups, the score of the treatment group after treatment was lower than that of the control group, which was statistically significant (P<0.05). See Table 2.

[0085] Table 2 Comparison of TCM syndrome scores between the two groups of granulomatous mastitis

[0086]

[0087] 3 Comparison of 5-hydroxytryptamine (5-HT) and norepinephrine (NE) levels between the two groups before and after treatment

[0088] After treatment, the levels of 5-HT and NE in both groups were significantly lower than those before treatment, with statistical significance (P<0.01). Compared with the control group, the decrease in the treatment group was more obvious, with statistical significance (P<0.01, P<0.05). See Tables 3 and 4.

[0089] Table 3 Comparison of 5-HT in two groups before and after treatment of granulomatous mastitis

[0090]

[0091] Table 4 Comparison of 5-HT in two groups before and after treatment of granulomatous mastitis

[0092]

[0093] 4 Comparison of prolactin (PRL) levels between the two groups before and after treatment

[0094] The PRL level in the treatment group decreased significantly before and after treatment, and the difference was statistically significant (P<0.01). After treatment, the PRL level in the treatment group was significantly lower than that in the control group, which was statistically significant (P<0.01). See Tables 5 and 6.

[0095] Table 5 Comparison of PRL before and after treatment of granulomatous mastitis in two groups

[0096]

[0097] 5 Comparison of immunoglobulin M (IgM) and immunoglobulin G (IgG) levels between the two groups

[0098]

[0099] Table 6 Comparison of IgG in the two groups before and after treatment of granulomatous mastitis

[0100]

[0101]

[0102] 6 Comparison of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) levels between the two groups before and after treatment

[0103] Compared with before treatment, the levels of TNF-α and IL-6 in both groups decreased significantly after treatment (P<0.05), and the levels of TNF-α and IL-6 in the treatment group were significantly lower than those in the control group (P<0.05). See Tables 7 and 8.

[0104] Table 7 Comparison of TNF-α in two groups before and after treatment of granulomatous mastitis

[0105]

[0106] Table 8 Comparison of IL-6 in two groups of granulomatous mastitis before and after treatment

[0107]

[0108] In this study, no adverse reactions occurred in the treatment group during the treatment process; 4 cases of the control group had symptoms of loss of appetite, nausea, and vomiting; 2 patients had abnormal liver and kidney function, and the total adverse reaction rate was 18.92%. Compared with the control group, the incidence of adverse reactions in the treatment group was lower, and the difference was statistically significant (P < 0.01). See Table 9.

[0109] Table 9 Comparison of adverse reactions between the two groups

[0110]

[0111] 8 Comparison of recurrence between the two groups

[0112] After the treatment, the patients who were cured, markedly effective and effective were followed up for 6 months (regular follow-up visits or phone calls), and there were no cases lost to follow-up. One case relapsed in the treatment group, with a relapse rate of 2.86% (1 / 35), and 14 cases relapsed in the control group, with a relapse rate of 45.16% (14 / 31). There was a statistically significant difference between the two groups (P<0.05). See Table 10.

[0113] Table 10 Comparison of adverse reactions between the two groups

[0114]

[0115] In this experiment, by tracking the levels of 5-HT and NE in the peripheral blood of patients with granulomatous mastitis due to liver meridian heat accumulation syndrome, it was found that their levels increased significantly after treatment, and compared with the control group, the improvement effect of the treatment group was more obvious (P>0.05). This shows that the healing trend of the disease is positively correlated with 5-HT and NE. In addition, the experiment found that the prolactin levels of the patients in the treatment group decreased significantly before and after treatment. Prolactin (PRL) is a protein hormone secreted by pituitary lactocytes. Its main function is to promote the secretion of milk by the mammary gland. Studies have shown

[16] Emotional changes such as depression, impatience, panic, and stress can significantly affect the secretion level of PRL. It has been confirmed that prolactin is an important neuroendocrine factor involved in immune regulation. PRL can promote the activation of human peripheral blood B cells and secrete a large amount of IgG, IgM and IgA.

[20] In the experiment by Peeva E et al.

[21] , rat thymic dendritic cells can express PRL, and dendritic cells stimulated by PRL can produce a large number of inflammatory factors, such as IL-12, TNF-α, IL-1β, etc. Physiological levels of PRL maintain normal immune function by regulating the body's cellular immunity and humoral immunity. We can find that in this experiment, as prolactin decreases in the treatment group, IgM, IgG, TNF-α, and IL-6 all decrease synchronously, which is consistent with the literature. Research reports have confirmed

[22] , the nervous system, endocrine system and immune system are closely connected, that is, the nervous system can jointly regulate the function of the immune system through neurotransmitters, endocrine hormones and cytokines, and the immune system can feedback to the nervous system and endocrine system through a variety of cytokines and hormone-like substances produced by immune cells. The three systems can communicate and regulate each other. The three together constitute a complete regulatory network. Traditional Chinese medicine treatment of GLM has the characteristics of multi-target, multi-link, multi-level and multi-center, and it is difficult to explain the efficacy mechanism of traditional Chinese medicine from a single mechanism. The two coincide. Therefore, this experiment explores the overall functional behavior of the body under the state of liver meridian accumulation heat syndrome in granulomatous mastitis in the mass stage from the perspective of the nervous-endocrine-immune network and the relationship between its different levels, so as to explore the utility principle that enables the neural-endocrine-immune (NEI) network to establish a steady-state balance, which is more feasible and has a certain foresight.

[0116] In summary, the Chinese medicine for oral administration of the present invention is used to treat granulomatous mastitis with liver meridian heat accumulation syndrome in the mass stage. Compared with the oral use of hormones, the total effective rate is high, the TCM syndrome score is more improved, and the adverse reactions and recurrence rate are significantly superior. This scheme preliminarily observed the intervention effect of Chinese medicine oral prescriptions from the neuro-endocrine-immune network. The results showed that the prescriptions prepared by our hospital can regulate the NEI network, improve immune function, and downregulate inflammatory factors, which is of great significance for the treatment of granulomatous mastitis with liver meridian heat accumulation syndrome in the mass stage.

[0117] Experimental Example 2

[0118] General information: A total of 114 GLM patients were finally included in this study, all from the Thyroid and Breast Surgery Ward of Taicang Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Chinese Medicine from October 2020 to October 2023. The study adopted a prospective, randomized, controlled method, and divided the patients into control group, experimental group 1, and experimental group 2; experimental group 1 had 38 cases; experimental group 2 had 38 cases; and the control group had 38 cases.

[0119] Experimental Group 1: Chinese herbal medicine for oral administration according to Example 1

[0120] Experimental Group 2: Oral Chinese medicine of Example 2

[0121] Control group: oral prednisone acetate tablets [Tianjin Xinyi Jinjin Pharmaceutical Co., Ltd., national medicine standard H31020675], 30 mg / d -1 Compared with the control group, the total effective rate of the experimental group was higher, see Table 11.

[0122] Table 11 Comparison of clinical efficacy of granulomatous mastitis between two groups

[0123]

[0124] The experiment shows that the effective rates of the oral Chinese medicine of Example 1 and the oral Chinese medicine of Example 2 are both better than those of the control group; compared with the oral Chinese medicine of Example 2, the oral Chinese medicine of Example 1 has the same medicinal taste, but different medicinal taste ratios. Compared with the oral Chinese medicine of Example 1, the therapeutic effect of the oral Chinese medicine of Example 2 is better.

[0125] Experimental Example 3

[0126] General information: A total of 117 GLM patients were finally included in this study, all from the Thyroid and Breast Surgery Ward of Taicang Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Chinese Medicine from October 2020 to October 2023. The study adopted a prospective, randomized, controlled method, and divided the patients into control group, experimental group 1, and experimental group 2; experimental group 1 had 39 cases; experimental group 2 had 39 cases; and the control group had 39 cases.

[0127] Experimental Group 1: Chinese herbal medicine for oral administration according to Example 3

[0128] Experimental Group 2: Oral Chinese medicine of Example 2

[0129] Control group: oral prednisone acetate tablets [Tianjin Xinyi Jinjin Pharmaceutical Co., Ltd., national medicine standard H31020675], 30 mg / d -1 Compared with the control group, the experimental group had a higher total effective rate, see Table 12.

[0130] Table 12 Comparison of clinical efficacy of granulomatous mastitis between two groups

[0131]

[0132] The experiment shows that the effective rates of the oral Chinese medicine of Example 3 and the oral Chinese medicine of Example 2 are both better than those of the control group. Compared with the oral Chinese medicine of Example 2, the oral Chinese medicine of Example 1 has the same medicinal taste, but different medicinal taste ratios. Compared with the oral Chinese medicine of Example 3, the therapeutic effect of the oral Chinese medicine of Example 2 is better.

[0133] Experimental Example 4

[0134] General information: A total of 120 GLM patients were finally included in this study, all from the Thyroid and Breast Surgery Ward of Taicang Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Chinese Medicine from October 2020 to October 2023. The study adopted a prospective, randomized, controlled method, and divided the patients into control group, experimental group 1, and experimental group 2; experimental group 1 had 40 cases; experimental group 2 had 40 cases; and the control group had 40 cases.

[0135] Experimental Group 1: Chinese herbal medicine for oral administration according to Example 4

[0136] Experimental Group 2: Oral Chinese medicine of Example 2

[0137] Control group: oral prednisone acetate tablets [Tianjin Xinyi Jinjin Pharmaceutical Co., Ltd., national medicine standard H31020675], 30 mg / d -1 Compared with the control group, the total effective rate of the experimental group was higher, see Table 13

[0138] Table 13 Comparison of clinical efficacy of granulomatous mastitis between the two groups.

[0139]

[0140] The experiment shows that the effective rates of the oral Chinese medicine of Example 4 and the oral Chinese medicine of Example 2 are both better than those of the control group; compared with the oral Chinese medicine of Example 2, the oral Chinese medicine of Example 4 has the same medicinal taste, but different medicinal taste ratios. Compared with the oral Chinese medicine of Example 4, the therapeutic effect of the oral Chinese medicine of Example 2 is better.

[0141] Experimental Example 5

[0142] General information: A total of 117 GLM patients were finally included in this study, all from the Thyroid and Breast Surgery Ward of Taicang Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Chinese Medicine from October 2020 to October 2023. The study adopted a prospective, randomized, controlled method, and divided the patients into control group, experimental group 1, and experimental group 2; experimental group 1 had 39 cases; experimental group 2 had 39 cases; and the control group had 39 cases.

[0143] Experimental Group 1: Chinese herbal medicine for oral administration according to Example 5

[0144] Experimental Group 2: Oral Chinese medicine of Example 2

[0145] Control group: oral prednisone acetate tablets [Tianjin Xinyi Jinjin Pharmaceutical Co., Ltd., national medicine standard H31020675], 30 mg / d -1 After treatment, the levels of IgM and IgG in the peripheral blood of the experimental group were significantly lower than those of the control group and before treatment. See Tables 14 and 15.

[0146] Table 14 Comparison of IgM before and after treatment of granulomatous mastitis in two groups

[0147]

[0148] Table 15 Comparison of IgG before and after treatment of granulomatous mastitis in two groups

[0149]

[0150] Experiments show that:

[0151] Compared with Example 2, the oral Chinese medicine in Example 2 lacks Radix Rehmanniae and Radix Paeoniae Alba, wherein the oral Chinese medicine in Example 2 is equipped with Radix Rehmanniae and Radix Paeoniae Alba, which are yin and soft products and blood-blood medicines. They are matched with spicy angelica and Rhizoma Chuanxiong (blood-qi medicines), combining movement and stillness, nourishing without stagnation, nourishing without greasy, and all four substances enter the liver meridian, nourishing blood and softening the liver, and can also treat blood deficiency and fire movement, and also have the meaning of "treating collaterals first treat blood, and blood and collaterals will be unblocked".

[0152] Therefore, the therapeutic effect in Example 2 is significantly better than that in Example 5. The contents of IgM and IgG in the peripheral blood of Example 2, from the perspective of modern physiology, are mainly influencing factors of immunity. On the surface, white peony root and raw rehmannia have a significant effect on the regulation of the immune network when establishing the balance of the neuro-endocrine-immune network.

[0153] Experimental Example 6

[0154] General information: A total of 117 GLM patients were finally included in this study, all from the Thyroid and Breast Surgery Ward of Taicang Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Chinese Medicine from October 2020 to October 2023. The study adopted a prospective, randomized, controlled method, and divided the patients into control group, experimental group 1, and experimental group 2; experimental group 1 had 39 cases; experimental group 2 had 39 cases; and the control group had 39 cases.

[0155] Experimental Group 1: Oral Chinese medicine of Example 6

[0156] Experimental Group 2: Oral Chinese medicine of Example 2

[0157] Control group: oral prednisone acetate tablets [Tianjin Xinyi Jinjin Pharmaceutical Co., Ltd., national medicine standard H31020675], 30 mg / d -1 Comparison between the two groups showed that after treatment, the PRL level in the experimental group was significantly lower than that in the control group (see Table 16).

[0158] Table 16 Comparison of PRL before and after treatment of granulomatous mastitis in two groups

[0159]

[0160] The experiment shows that the effective rates of the oral Chinese medicine of Example 6 and the oral Chinese medicine of Example 2 are better than those of the control group; compared with the oral Chinese medicine of Example 2, the composition of Example 6 lacks two medicinal flavors of rose and raw malt, and the number and proportion of other medicinal flavors are the same; in Example 2, rose and raw malt are used to relieve depression, regulate qi and dredge collaterals, rose has the effects of promoting qi and relieving depression, promoting blood circulation and regulating menstruation, raw malt strengthens the spleen and stomach and promotes lactation, and is used for spleen deficiency, poor appetite, and milk and sweat accumulation. From the perspective of modern physiology, when establishing the balance of the neuro-endocrine-immune network; it mainly has a significant effect on promoting balance in the endocrine link. Therefore, the therapeutic effect in Example 2 is significantly better than that in Example 6.

[0161] Experimental Example 7

[0162] General information: A total of 114 GLM patients were finally included in this study, all from the Thyroid and Breast Surgery Ward of Taicang Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Chinese Medicine from October 2020 to October 2023. The study adopted a prospective, randomized, controlled method, and divided the patients into control group, experimental group 1, and experimental group 2; experimental group 1 had 38 cases; experimental group 2 had 38 cases; and the control group had 38 cases.

[0163] Experimental group 1: the oral Chinese medicine of Example 7;

[0164] Experimental group 2: the oral Chinese medicine of Example 2;

[0165] Control group: oral prednisone acetate tablets [Tianjin Xinyi Jinjin Pharmaceutical Co., Ltd., national medicine standard H31020675], 30 mg / d -1 Compared with the control group, the decrease in the experimental group was more obvious, see Table 17.

[0166] Table 17 Comparison of TCM syndrome scores between the two groups of granulomatous mastitis

[0167]

[0168] The experiment shows that the effective rates of the compound of Example 7 and the oral Chinese medicine of Example 2 are better than those of the control group; compared with the oral Chinese medicine of Example 2, the compound of Example 7 lacks two medicinal ingredients of whole Trichosanthes and Bombyx Batryticatus, and the number and proportion of other medicinal ingredients are the same; the main effects of whole Trichosanthes and Bombyx Batryticatus in Example 2 are: unblocking meridians and dispersing nodules. Therefore, the TCM syndrome score of bud tumor mastitis in Example 2 is significantly better than that in Example 7, mainly due to the therapeutic effects of whole Trichosanthes and Bombyx Batryticatus.

[0169] The above is only a preferred embodiment of the present invention. It should be pointed out that ordinary technicians in this technical field can make several improvements and supplements without departing from the principle of the present invention. These improvements and supplements should also be regarded as the scope of protection of the present invention.

Claims

1. A Chinese medicine oral medicine for treating granulomatous mastitis mass stage based on neuro-endocrine-immune network, characterized in that: The raw material composition and weight fraction of the effective ingredients of the oral Chinese medicine are as follows: 15-25g of raw rehmannia, 25-35g of white peony root, 15-25g of angelica, 15-25g of chuanxiong, 10-20g of bupleurum, 10-20g of cyperus, 10-20g of green tangerine peel, 10-15g of rose, 15-25g of raw malt, 15-25g of whole trichosanthes, 15-25g of sapodilla thorn, 15-25g of bombyx batryticatus, 10-20g of trichosanthes, 10-20g of dandelion, and 10-20g of forsythia.

2. The oral Chinese medicine according to claim 1, characterized in that: The raw material composition and weight fraction of the effective ingredients of the oral Chinese medicine are: 20g of raw rehmannia, 30g of white peony root, 20g of angelica, 20g of chuanxiong, 15g of bupleurum, 15g of cyperus, 15g of green peel, 10g of rose, 15g of raw malt, 20g of whole trichosanthes, 20g of sapodilla thorn, 20g of bombyx batryticatus, 15g of trichosanthes root, 15g of dandelion and 15g of forsythia.

3. The oral Chinese medicine according to claim 1, characterized in that: The raw material composition and weight fraction of the effective ingredients of the oral Chinese medicine are: 15g of raw rehmannia, 25g of white peony root, 15g of angelica, 15g of chuanxiong, 10g of bupleurum, 10g of cyperus, 10g of green peel, 10g of rose, 15g of raw malt, 15g of whole trichosanthes, 15g of sapodilla thorn, 15g of bombyx batryticatus, 10g of trichosanthes root, 10g of dandelion and 10g of forsythia.

4. The oral Chinese medicine according to claim 1, characterized in that: The raw material composition and weight fraction of the effective ingredients of the oral Chinese medicine are: 25g of raw rehmannia, 30g of white peony root, 25g of angelica, 25g of chuanxiong, 20g of bupleurum, 20g of cyperus, 20g of green peel, 15g of rose, 25g of raw malt, 25g of whole trichosanthes, 25g of sapodilla thorn, 25g of bombyx batryticatus, 20g of trichosanthes root, 20g of dandelion and 20g of forsythia.

5. The oral Chinese medicine according to claim 1-4, characterized in that: The radix bupleuri is vinegar bupleuri.

6. A method for preparing the Chinese medicinal oral medicine for treating the mass stage of granulomatous mastitis based on the neuro-endocrine-immune network as described in claims 1-4, characterized in that: The following steps are involved: S1: Weigh raw rehmannia root, white peony root, Chinese angelica root, ligusticum chuanxiong, bupleurum root, cyperus rotundus, green peel, rose flower, raw malt, whole trichosanthes root, licorice thorn, bombyx batryticatus, radix trichosanthis, dandelion, forsythia suspensa by weight, wash and mix, microwave-dry and set aside; S2: the raw material prepared in step S1 is chopped, boiled in water for 1-2 hours, filtered, the residue is boiled in water for another 1-2 hours, the two filtrates are combined, concentrated, and cooled naturally; S3: Add pharmaceutical excipients, package and sterilize to obtain oral solution.

7. A method for preparing the Chinese herbal oral medicine for treating the mass stage of granulomatous mastitis based on the neuro-endocrine-immune network as claimed in claim 6, characterized in that: The pharmaceutical excipient in step S3 is sucrose or monosaccharide syrup.

Citation Information

Patent Citations

  • Medicament for treating mastitis, and preparation method thereof

    CN103356802A